Therapeutic management of type 1 diabetes before and during pregnancy

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 5, 2011, Pages 779-786

  Mathiesen, Elisabeth R ^a,b,c   Ringholm, Lene ^a,b   Damm, Peter ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

antihypertensive treatment; diabetes; insulin analogues; pre conception counseling; pregnancy; prepregnancy; type 1 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; FOLIC ACID; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LABETALOL; LONG ACTING INSULIN; METHYLDOPA; NIFEDIPINE; PIG INSULIN; PROPYLTHIOURACIL; SHORT ACTING DRUG;

ABSENCE OF SIDE EFFECTS; ADVERSE OUTCOME; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CONTINUOUS INFUSION; DIABETES EDUCATION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EVIDENCE BASED MEDICINE; FAMILY COUNSELING; FETUS MALFORMATION; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL HYPERTENSION; MICROALBUMINURIA; OBSTETRIC CARE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; THYROID DISEASE; TREATMENT PLANNING;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME;

EID: 79952610265     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2011.540388     Document Type: Review

References (71)

1. Boulot P, Chabbert-Buffet N, d'Ercole C, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes2. Diabetes Care 2003;26:2990-3
2. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997;315:275-8 (Pubitemid 27326208)
3. Confidential Enquiery into Maternal and Child Health. Confidential Enquiry into Maternal and Child Health: pregnancy in Women with Type 1 and Type 2 Diabetes in 2002-3, Wales and Northern Ireland, CEMACH, England; 2005
4. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004;328:915
5. Hawthorne G, Robson S, Ryall EA, et al. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 1997;315:279-81 (Pubitemid 27326231)
6. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004;27:2819-23 (Pubitemid 39565043)
7. Lapolla A, Dalfra MG, Spezia R, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol 2008;45:61-6
8. Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 2006;333:177
9. Penney GC, Mair G, Pearson DW. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 2003;110:315-8 (Pubitemid 36298919)
10. Platt MJ, Stanisstreet M, Casson IF, et al. St Vincent's declaration 10 years on: outcomes of diabetic pregnancies. Diabet Med 2002;19:216-20 (Pubitemid 34429652)
11. Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006;108:644-50 (Pubitemid 44337107)
12. Temple RC, Aldridge VJ, Murphy HR Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006;29:1744-9 (Pubitemid 44156624)
13. Wilson RD, Davies G, Desilets V, et al. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003;25:959-73
14. Capel I, Corcoy R. What dose of folic acid should be used for pregnant diabetic women? Diabetes Care 2007;30:63
15. Inkster ME, Fahey TP, Donnan PT, et al. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 2006;6:30
16. Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009;32:1046-8
17. Vestgaard M, Nielsen LR, Rasmussen AK, et al. Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: impact on thyroid function, metabolic control and pregnancy outcome. Acta Obstet Gynecol Scand 2008;87:1336-42
18. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-55 (Pubitemid 29384162)
19. Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007;92:S1-47
20. Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 1996;19:1067-74 (Pubitemid 26334253)
21. Damm P, Mathiesen E, Clausen TD, Petersen KR Contraception for women with diabetes mellitus. Metab Syndr Relat Disord 2005;3:244-9 (Pubitemid 41601242)
22. Homko CJ, Sivan E, Reece AE. Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy? Treat Endocrinol 2004;3:133-9 (Pubitemid 38724499)
23. British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain London. 2006
24. Hod M, Damm P, Kaaja R, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186-7
25. Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771-6 (Pubitemid 46556565)
26. Mathiesen ER, Vaz JA. Insulin treatment in diabetic pregnancy. Diabetes Metab Res Rev 2008;24(Suppl 2):S3-20
27. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with Type 1 diabetes. Diabet Med 2008;25:165-9 (Pubitemid 351293402)
28. Lapolla A, Di CG, Bruttomesso D, et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women. Diabet Med 2009;26:1181-2
29. Poyhonen-Alho M, Ronnemaa T, Saltevo J, et al. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand 2007;29:1-4
30. National Institute of Health and Clinical Excellence. Diabetes in Pregnancy. Management of Diabetes and its Complications from Pre-conception to the Post Natal Period. Available from: www.nice.org.uk/CG063 Nice Clinical guideline. 2008
31. Kitzmiller JL. Obstetrical management of women with preexisting diabetes mellitus. Managing preexisting diabetes and pregnancy. American Diabetes Association technical reviews and consensus recommendations for care. 2008. p. 561-601
32. Kerssen A, de Valk HW, Visser GH. Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia 2006;49:25-8 (Pubitemid 43151609)
33. Schrot RJ. Targeting plasma glucose: preprandial versus postprandial. Clin Diabetes 2004;22:169-72
34. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels ofHbA(1c). Diabetes Care 2003;26:881-5 (Pubitemid 36929359)
35. Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008;337:a1680
36. Nielsen LR, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004;27:1200-1 (Pubitemid 38579790)
37. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. The Kroc Collaborative Study Group. N Engl J Med 1984;311:365-72
38. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86
39. Lawson PM, Champion MC, Canny C, et al. Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. Br J Ophthalmol 1982;66:762-6 (Pubitemid 13254877)
40. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care 1995;18:631-7
41. Vestgaard M, Ringholm L, Laugesen CS, et al. Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes. Diabet Med 2010;27:431-5
42. Evers IM, ter Braak EW, de Valk HW, et al. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002;25:554-9 (Pubitemid 41103352)
43. Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 1992;15:1034-7
44. Leinonen PJ, Hiilesmaa VK, Kaaja RJ, Teramo KA. Maternal mortality in type 1 diabetes. Diabetes Care 2001;24:1501-2
45. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role ofmetabolic control1. Diabetes Care 2008;31:9-14
46. Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417-22
47. Buchanan TA, Schemmer JK, Freinkel N. Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J Clin Invest 1986;78:643-9 (Pubitemid 16024797)
48. Kawaguchi M, Tanigawa K, Tanaka O, Kato Y. Embryonic growth impaired by maternal hypoglycemia during early organogenesis in normal and diabetic rats. Acta Diabetol 1994;31:141-6 (Pubitemid 24306995)
49. Smoak IW, Sadler TW. Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro2. Am J Obstet Gynecol 1990;163:619-24 (Pubitemid 20287647)
50. Worm D, Nielsen LR, Mathiesen ER, Norgaard K. Continuous glucose monitoring system with an alarm: a tool to reduce hypoglycemic episodes in pregnancy with diabetes. Diabetes Care 2006;29:2759-60 (Pubitemid 44912218)
51. Hanson U, Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998;77:620-4 (Pubitemid 28416507)
52. Siddiqi T, Rosenn B, Mimouni F, et al. Hypertension during pregnancy in insulin-dependent diabetic women. Obstet Gynecol 1991;77:514-19
53. Bartha JL, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol 2002;187:735-40
54. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003;88:2393-8 (Pubitemid 36724402)
55. Sierra-Laguado J, Garcia RG, Celedon J, et al. Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension. Am J Hypertens 2007;20:437-42 (Pubitemid 46441759)
56. Solomon CG, Seely EW. Briefreview: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 2001;37:232-9 (Pubitemid 32199080)
57. Ferriss JB. The causes of raised blood pressure in insulin-dependent and non-insulin-dependent diabetes. J Hum Hypertens 1991;5:245-54
58. Leguizamon GF, Zeff NP, Fernandez A. Hypertension and the pregnancy complicated by diabetes. Curr Diab Rep 2006;6:297-304 (Pubitemid 44322702)
59. Jensen T, Deckert T. Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients. Horm Metab Res 1992;26(Suppl):68-70 (Pubitemid 23017870)
60. Aoki TT, Grecu EO, Gollapudi GM, et al. Effect of intensive insulin therapy on progression of overt nephropathy in patients with type 1 diabetes mellitus. Endocr Pract 1999;5:174-8
61. Kawazu S, Tomono S, Shimizu M, et al. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study. J Diabetes Complications 1994;8:13-17 (Pubitemid 24371436)
62. Mulec H, Blohme G, Grande B, Bjorck S. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Nephrol Dial Transplant 1998;13:651-5 (Pubitemid 28119047)
63. Nielsen LR, Muller C, Damm P, Mathiesen ER. Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria-possible effect of early antihypertensive treatment during pregnancy. Diabet Med 2006;23:426-31
64. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51 (Pubitemid 43855047)
65. Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin- converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994;96:451-6 (Pubitemid 24156732)
66. Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009;32:38-44
67. Mathiesen ER, Damm P. Pregnancy-pharmacological problems. Mogensen CE, editor, Pharmacotherapy of diabetes: new developments. 2009. p. 249-55
68. Jovanovic L. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes. Endocr Pract 2004;10(Suppl 2):40-5
69. Stage E, Mathiesen ER, Emmersen PB, et al. Diabetic mothers and their newborn infants-rooming-in and neonatal morbidity. Acta Paediatr 2010;99:997-9
70. Stage E, Norgard H, Damm P, Mathiesen E. Long-term breast-feeding in women with type 1 diabetes. Diabetes Care 2006;29:771-4 (Pubitemid 44115292)
71. Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990;7:360